Aggressive Treatment in Pediatric Patients With Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Is Associated With Future Development of Type III Polyglandular Autoimmune Syndrome

    October 2018 in “ BMJ Case Reports ”
    Chiyo Morita, Tetsuji Yanase, Tetsuo Shiohara, Yumi Aoyama
    TLDR Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.
    The study discussed a 6-year-old boy with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) who developed type III polyglandular autoimmune syndrome (PASIII) following aggressive treatment with intravenous immunoglobulin (IVIG) and prednisolone. A literature review identified five similar cases, suggesting that while these treatments were effective short-term, they might increase the risk of long-term autoimmune issues in pediatric patients. The study recommended careful screening for autoantibodies and advised against therapies that could hasten immune recovery, potentially leading to PASIII.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results